MENU
You are the chief privacy officer of a medical research company that would like to collect and use sensitive data about cancer patients, such as their names, addresses, race and ethnic origin, medical histories, insurance claims, pharmaceutical prescriptions, eating and drinking habits and physical activity.
The company will use this sensitive data to build an Al algorithm that will spot common attributes that will help predict if seemingly healthy people are more likely to get cancer. However, the company is unable to obtain consent from enough patients to sufficiently collect the minimum data to train its model.
Which of the following solutions would most efficiently balance privacy concerns with the lack of available data during the testing phase?
Utilizing synthetic data to offset the lack of patient data is an efficient solution that balances privacy concerns with the need for sufficient data to train the model. Synthetic data can be generated to simulate real patient data while avoiding the privacy issues associated with using actual patient data. This approach allows for the development and testing of the AI algorithm without compromising patient privacy, and it can be refined with real data as it becomes available. Reference: AIGP Body of Knowledge on Data Privacy and AI Model Training.